title: [Lymphoblastic leukemia and immunological markers].
abstract: Acute lymphoblastic leukemia (ALL) is a heterogeneous entity that can be subcategorized on the basis of morphologic aspects, membrane antigens, caryotypic analysis and enzymatic content of the blast cells. Subgroups corresponding to T cells, Band pre-B cells, and non T non B lymphocytes derivations can be defined by immunologic markers. These studies ease the diagnosis and characterisation of ALL, perhaps their treatment, and enhance understanding of the disease.
authors.affiliation: Service de Médecine D, C. H. U. d'Angers.
authors.forename: N
authors.initials: N
authors.lastname: Ifrah
authors.forename: J Y
authors.initials: JY
authors.lastname: Perrot
authors.forename: J P
authors.initials: JP
authors.lastname: Marie
authors.forename: M
authors.initials: M
authors.lastname: Boasson
authors.forename: R
authors.initials: R
authors.lastname: Zittoun
mesh_terms: D000943:Antigens, Differentiation / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000145:classification / Q000276:immunology / Q000473:pathology; D008221:Lymphoid Tissue / Q000033:anatomy & histology / Q000276:immunology; D010641:Phenotype; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000943:Antigens, Differentiation
vernacular_title: Leucémies aiguës lymphoblastiques et marqueurs immunologiques.